Document is current
Any future updates will be listed below
-
Authors
Ma, Feiyang https://orcid.org/0000-0002-6260-0787
Tsou, Pei-Suen
Gharaee-Kermani, Mehrnaz
Plazyo, Olesya
Xing, Xianying
Kirma, Joseph
Wasikowski, Rachael https://orcid.org/0000-0003-3544-3023
Hile, Grace A.
Harms, Paul W. https://orcid.org/0000-0002-0802-2883
Jiang, Yanyun
Xing, Enze https://orcid.org/0000-0001-9358-9368
Nakamura, Mio
Ochocki, Danielle
Brodie, William D.
Pillai, Shiv https://orcid.org/0000-0002-9905-875X
Maverakis, Emanual
Pellegrini, Matteo https://orcid.org/0000-0001-9355-9564
Modlin, Robert L. https://orcid.org/0000-0003-4720-031X
Varga, John
Tsoi, Lam C.
Lafyatis, Robert https://orcid.org/0000-0002-9398-5034
Kahlenberg, J. Michelle https://orcid.org/0000-0002-4006-8945
Billi, Allison C. https://orcid.org/0000-0001-7115-9113
Khanna, Dinesh https://orcid.org/0000-0003-1412-4453
Gudjonsson, Johann E. https://orcid.org/0000-0002-0080-0812
- License Information
-
More Information
Article History
Received: 27 February 2023
Accepted: 23 December 2023
First Online: 3 January 2024
Competing interests
: J.E.G. has received Grant support from Celgene/BMS, Janssen, Eli Lilly, and Almirall. J.E.G. has served on advisory boards for AstraZeneca, Sanofi, Eli Lilly, Boehringer Ingelheim, Novartis, Janssen, Almirall, BMS. J.M.K. has received Grant support from Q32 Bio, Celgene/BMS, Ventus Therapeutics, and Janssen. J.M.K. has served on advisory boards for AstraZeneca, Eli Lilly, GlaxoSmithKline, Bristol Myers Squibb, Avion Pharmaceuticals, Provention Bio, Aurinia Pharmaceuticals, Ventus Therapeutics, Vera Therapeutics, and Boehringer Ingelheim. P.W.H. has received effort support from Q32 Bio. The remaining authors declare no competing interests.
